TrialAnnals of oncology : official journal of the European Society for Medical Oncology2012

Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.

J M Pipas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.